Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae

The 2,160,267 bp genome sequence of Streptococcus agalactiae, the leading cause of bacterial sepsis, pneumonia, and meningitis in neonates in the U.S. and Europe, is predicted to encode 2,175 genes. Genome comparisons among S. agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, and the other completely sequenced genomes identified genes specific to the streptococci and to S. agalactiae. These in silico analyses, combined with comparative genome hybridization experiments between the sequenced serotype V strain 2603 V/R and 19 S. agalactiae strains from several serotypes using whole-genome microarrays, revealed the genetic heterogeneity among S. agalactiae strains, even of the same serotype, and provided insights into the evolution of virulence mechanisms.

[1]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[2]  L. Madoff,et al.  Mosaicism in the alpha-like protein genes of group B streptococci. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Azimi,et al.  Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. , 1997, The Journal of infectious diseases.

[4]  V. Nizet,et al.  Genetic basis for the β‐haemolytic/cytolytic activity of group B Streptococcus , 2001, Molecular microbiology.

[5]  B. Bensing,et al.  Proteins PblA and PblB of Streptococcus mitis, Which Promote Binding to Human Platelets, Are Encoded within a Lysogenic Bacteriophage , 2001, Infection and Immunity.

[6]  B. Spellerberg,et al.  Horizontal gene transfer and host specificity of beta‐haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb , 2001, Molecular microbiology.

[7]  F. Michel,et al.  Mutually Exclusive Distribution of IS1548 and GBSi1, an Active Group II Intron Identified in Human Isolates of Group B Streptococci , 2001, Journal of bacteriology.

[8]  G. Lindahl,et al.  Identification of a Family of Streptococcal Surface Proteins with Extremely Repetitive Structure* , 1996, The Journal of Biological Chemistry.

[9]  Vasu Punj,et al.  Adenylate Kinase as a Virulence Factor ofPseudomonas aeruginosa , 2001, Journal of bacteriology.

[10]  M. Frosch,et al.  Rapid serogroup switching in Neisseria meningitidis. , 2000, The New England journal of medicine.

[11]  C. Rubens,et al.  Genetic Loci of Streptococcus mitis That Mediate Binding to Human Platelets , 2001, Infection and Immunity.

[12]  F. Fiedler,et al.  Interaction between the protein InlB of Listeria monocytogenes and lipoteichoic acid: a novel mechanism of protein association at the surface of Gram‐positive bacteria , 1999, Molecular microbiology.

[13]  I. Charlebois,et al.  Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective Immunity , 2000, Infection and Immunity.

[14]  P. Cieslak,et al.  Capsule switching of Neisseria meningitidis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ian T. Paulsen,et al.  Complete genome sequence of Caulobacter crescentus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  V. Sharov,et al.  Gene Expression Analysis of the Streptococcus pneumoniae Competence Regulons by Use of DNA Microarrays , 2000, Journal of bacteriology.

[17]  Manuel G. Claros,et al.  TopPred II: an improved software for membrane protein structure predictions , 1994, Comput. Appl. Biosci..

[18]  J. Venter,et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.

[19]  J. Zhou,et al.  Horizontal transfer of multiple penicillin‐binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae , 1991, Molecular microbiology.

[20]  S. Brunak,et al.  SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .

[21]  B. Spratt,et al.  Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae , 1998, Molecular microbiology.

[22]  D. Pritchard,et al.  Group B streptococcal neuraminidase is actually a hyaluronidase , 1993, Infection and immunity.

[23]  N. Lee,et al.  A concise guide to cDNA microarray analysis. , 2000, BioTechniques.

[24]  Fan Yang,et al.  TIGRFAMs: a protein family resource for the functional identification of proteins , 2001, Nucleic Acids Res..

[25]  S. Salzberg,et al.  Improved microbial gene identification with GLIMMER. , 1999, Nucleic acids research.

[26]  R. Platt,et al.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Henry C. Wu,et al.  Lipoproteins in bacteria , 1990, Journal of bioenergetics and biomembranes.

[28]  N. Dhiman,et al.  Phagocytic Cell Killing Mediated by Secreted Cytotoxic Factors of Vibrio cholerae , 2000, Infection and Immunity.

[29]  R. Fleischmann,et al.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.

[30]  G. Tyrrell,et al.  Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. , 2000, The Journal of infectious diseases.

[31]  A. Tomasz,et al.  Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. , 1995, The Journal of infectious diseases.

[32]  D. Kasper,et al.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. , 1982, Journal of immunology.

[33]  A. Schuchat,et al.  Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. , 1998, The Journal of infectious diseases.

[34]  S. Salzberg,et al.  Microbial gene identification using interpolated Markov models. , 1998, Nucleic acids research.

[35]  A. Schuchat,et al.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. , 1994, Epidemiologic reviews.

[36]  T. Meyer,et al.  Transformation-mediated exchange of virulence determinants by co-cultivation of pathogenic Neisseriae. , 1992, FEMS microbiology letters.

[37]  W R Pearson,et al.  Flexible sequence similarity searching with the FASTA3 program package. , 2000, Methods in molecular biology.

[38]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Salzberg,et al.  Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniae , 2001, Science.

[40]  H. Yim,et al.  The Serotype of Type Ia and III Group B Streptococci Is Determined by the Polymerase Gene within the Polycistronic Capsule Operon , 2000, Journal of bacteriology.